nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.277	0.5	CpDpCtD
Ketoprofen—osteoarthritis—Prednisone—ankylosing spondylitis	0.277	0.5	CpDpCtD
Ketoprofen—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0358	0.0913	CbGbCtD
Ketoprofen—PTGS2—Triamcinolone—ankylosing spondylitis	0.0346	0.0884	CbGbCtD
Ketoprofen—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0346	0.0884	CbGbCtD
Ketoprofen—SLCO1A2—Prednisone—ankylosing spondylitis	0.0338	0.0862	CbGbCtD
Ketoprofen—PTGS2—Betamethasone—ankylosing spondylitis	0.0297	0.0758	CbGbCtD
Ketoprofen—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0292	0.0746	CbGbCtD
Ketoprofen—SLC22A11—Methotrexate—ankylosing spondylitis	0.0254	0.0648	CbGbCtD
Ketoprofen—SLC22A7—Methotrexate—ankylosing spondylitis	0.0242	0.0617	CbGbCtD
Ketoprofen—ABCC4—Methotrexate—ankylosing spondylitis	0.0236	0.0603	CbGbCtD
Ketoprofen—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0211	0.0538	CbGbCtD
Ketoprofen—ALB—Prednisone—ankylosing spondylitis	0.0175	0.0445	CbGbCtD
Ketoprofen—PTGS2—Dexamethasone—ankylosing spondylitis	0.0173	0.0441	CbGbCtD
Ketoprofen—SLCO1A2—Methotrexate—ankylosing spondylitis	0.017	0.0433	CbGbCtD
Ketoprofen—SLC22A8—Methotrexate—ankylosing spondylitis	0.0148	0.0377	CbGbCtD
Ketoprofen—SLC22A6—Methotrexate—ankylosing spondylitis	0.0103	0.0262	CbGbCtD
Ketoprofen—ALB—Methotrexate—ankylosing spondylitis	0.00876	0.0223	CbGbCtD
Ketoprofen—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00842	0.0215	CbGbCtD
Ketoprofen—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00587	0.015	CbGbCtD
Ketoprofen—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000378	0.159	CbGdCrCtD
Ketoprofen—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000372	0.156	CbGdCrCtD
Ketoprofen—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000372	0.156	CbGdCrCtD
Ketoprofen—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000364	0.153	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000228	0.0958	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000225	0.0942	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000225	0.0942	CbGdCrCtD
Ketoprofen—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000219	0.0921	CbGdCrCtD
Ketoprofen—Hallucination—Prednisone—ankylosing spondylitis	0.000118	0.0023	CcSEcCtD
Ketoprofen—Malaise—Triamcinolone—ankylosing spondylitis	0.000117	0.00229	CcSEcCtD
Ketoprofen—Malaise—Methylprednisolone—ankylosing spondylitis	0.000117	0.00229	CcSEcCtD
Ketoprofen—Vertigo—Triamcinolone—ankylosing spondylitis	0.000117	0.00229	CcSEcCtD
Ketoprofen—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000117	0.00228	CcSEcCtD
Ketoprofen—Oedema—Prednisolone—ankylosing spondylitis	0.000115	0.00226	CcSEcCtD
Ketoprofen—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000115	0.00226	CcSEcCtD
Ketoprofen—Shock—Prednisolone—ankylosing spondylitis	0.000114	0.00222	CcSEcCtD
Ketoprofen—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000114	0.00222	CcSEcCtD
Ketoprofen—Convulsion—Triamcinolone—ankylosing spondylitis	0.000113	0.0022	CcSEcCtD
Ketoprofen—Tachycardia—Prednisolone—ankylosing spondylitis	0.000113	0.0022	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000113	0.0022	CcSEcCtD
Ketoprofen—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000112	0.0022	CcSEcCtD
Ketoprofen—Hypertension—Triamcinolone—ankylosing spondylitis	0.000112	0.0022	CcSEcCtD
Ketoprofen—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000112	0.00219	CcSEcCtD
Ketoprofen—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000112	0.00218	CcSEcCtD
Ketoprofen—Myalgia—Triamcinolone—ankylosing spondylitis	0.000111	0.00217	CcSEcCtD
Ketoprofen—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000111	0.00216	CcSEcCtD
Ketoprofen—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00011	0.00215	CcSEcCtD
Ketoprofen—Drowsiness—Methotrexate—ankylosing spondylitis	0.00011	0.00215	CcSEcCtD
Ketoprofen—Flushing—Prednisone—ankylosing spondylitis	0.00011	0.00214	CcSEcCtD
Ketoprofen—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00011	0.00214	CcSEcCtD
Ketoprofen—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00011	0.00214	CcSEcCtD
Ketoprofen—Discomfort—Triamcinolone—ankylosing spondylitis	0.000109	0.00214	CcSEcCtD
Ketoprofen—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000109	0.00214	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000109	0.00213	CcSEcCtD
Ketoprofen—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000108	0.00212	CcSEcCtD
Ketoprofen—Renal failure—Methotrexate—ankylosing spondylitis	0.000108	0.00211	CcSEcCtD
Ketoprofen—Angioedema—Dexamethasone—ankylosing spondylitis	0.000108	0.00211	CcSEcCtD
Ketoprofen—Angioedema—Betamethasone—ankylosing spondylitis	0.000108	0.00211	CcSEcCtD
Ketoprofen—Stomatitis—Methotrexate—ankylosing spondylitis	0.000107	0.0021	CcSEcCtD
Ketoprofen—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000107	0.00209	CcSEcCtD
Ketoprofen—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000107	0.00209	CcSEcCtD
Ketoprofen—Malaise—Betamethasone—ankylosing spondylitis	0.000106	0.00208	CcSEcCtD
Ketoprofen—Malaise—Dexamethasone—ankylosing spondylitis	0.000106	0.00208	CcSEcCtD
Ketoprofen—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000106	0.00208	CcSEcCtD
Ketoprofen—Oedema—Triamcinolone—ankylosing spondylitis	0.000106	0.00208	CcSEcCtD
Ketoprofen—Vertigo—Dexamethasone—ankylosing spondylitis	0.000106	0.00207	CcSEcCtD
Ketoprofen—Vertigo—Betamethasone—ankylosing spondylitis	0.000106	0.00207	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000106	0.00207	CcSEcCtD
Ketoprofen—Arrhythmia—Prednisone—ankylosing spondylitis	0.000105	0.00206	CcSEcCtD
Ketoprofen—Infection—Triamcinolone—ankylosing spondylitis	0.000105	0.00206	CcSEcCtD
Ketoprofen—Sweating—Methotrexate—ankylosing spondylitis	0.000105	0.00206	CcSEcCtD
Ketoprofen—Infection—Methylprednisolone—ankylosing spondylitis	0.000105	0.00206	CcSEcCtD
Ketoprofen—Haematuria—Methotrexate—ankylosing spondylitis	0.000105	0.00205	CcSEcCtD
Ketoprofen—Shock—Triamcinolone—ankylosing spondylitis	0.000104	0.00204	CcSEcCtD
Ketoprofen—Insomnia—Prednisolone—ankylosing spondylitis	0.000104	0.00204	CcSEcCtD
Ketoprofen—Alopecia—Prednisone—ankylosing spondylitis	0.000104	0.00204	CcSEcCtD
Ketoprofen—Shock—Methylprednisolone—ankylosing spondylitis	0.000104	0.00204	CcSEcCtD
Ketoprofen—Epistaxis—Methotrexate—ankylosing spondylitis	0.000104	0.00203	CcSEcCtD
Ketoprofen—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000104	0.00203	CcSEcCtD
Ketoprofen—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000104	0.00203	CcSEcCtD
Ketoprofen—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000103	0.00202	CcSEcCtD
Ketoprofen—Erythema—Prednisone—ankylosing spondylitis	0.000103	0.00201	CcSEcCtD
Ketoprofen—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000103	0.00201	CcSEcCtD
Ketoprofen—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000103	0.00201	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000102	0.002	CcSEcCtD
Ketoprofen—Convulsion—Dexamethasone—ankylosing spondylitis	0.000102	0.002	CcSEcCtD
Ketoprofen—Convulsion—Betamethasone—ankylosing spondylitis	0.000102	0.002	CcSEcCtD
Ketoprofen—Hypertension—Betamethasone—ankylosing spondylitis	0.000102	0.00199	CcSEcCtD
Ketoprofen—Hypertension—Dexamethasone—ankylosing spondylitis	0.000102	0.00199	CcSEcCtD
Ketoprofen—Myalgia—Betamethasone—ankylosing spondylitis	0.000101	0.00197	CcSEcCtD
Ketoprofen—Myalgia—Dexamethasone—ankylosing spondylitis	0.000101	0.00197	CcSEcCtD
Ketoprofen—Anxiety—Dexamethasone—ankylosing spondylitis	0.0001	0.00196	CcSEcCtD
Ketoprofen—Anxiety—Betamethasone—ankylosing spondylitis	0.0001	0.00196	CcSEcCtD
Ketoprofen—Discomfort—Betamethasone—ankylosing spondylitis	9.93e-05	0.00194	CcSEcCtD
Ketoprofen—Discomfort—Dexamethasone—ankylosing spondylitis	9.93e-05	0.00194	CcSEcCtD
Ketoprofen—Hepatitis—Methotrexate—ankylosing spondylitis	9.87e-05	0.00193	CcSEcCtD
Ketoprofen—Pharyngitis—Methotrexate—ankylosing spondylitis	9.8e-05	0.00192	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	9.67e-05	0.00189	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	9.65e-05	0.00189	CcSEcCtD
Ketoprofen—Anaphylactic shock—Betamethasone—ankylosing spondylitis	9.63e-05	0.00188	CcSEcCtD
Ketoprofen—Oedema—Betamethasone—ankylosing spondylitis	9.63e-05	0.00188	CcSEcCtD
Ketoprofen—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	9.63e-05	0.00188	CcSEcCtD
Ketoprofen—Oedema—Dexamethasone—ankylosing spondylitis	9.63e-05	0.00188	CcSEcCtD
Ketoprofen—Insomnia—Triamcinolone—ankylosing spondylitis	9.6e-05	0.00188	CcSEcCtD
Ketoprofen—Insomnia—Methylprednisolone—ankylosing spondylitis	9.58e-05	0.00187	CcSEcCtD
Ketoprofen—Infection—Betamethasone—ankylosing spondylitis	9.57e-05	0.00187	CcSEcCtD
Ketoprofen—Infection—Dexamethasone—ankylosing spondylitis	9.57e-05	0.00187	CcSEcCtD
Ketoprofen—Ill-defined disorder—Prednisone—ankylosing spondylitis	9.54e-05	0.00187	CcSEcCtD
Ketoprofen—Paraesthesia—Triamcinolone—ankylosing spondylitis	9.53e-05	0.00186	CcSEcCtD
Ketoprofen—Feeling abnormal—Prednisolone—ankylosing spondylitis	9.51e-05	0.00186	CcSEcCtD
Ketoprofen—Paraesthesia—Methylprednisolone—ankylosing spondylitis	9.51e-05	0.00186	CcSEcCtD
Ketoprofen—Visual impairment—Methotrexate—ankylosing spondylitis	9.51e-05	0.00186	CcSEcCtD
Ketoprofen—Anaemia—Prednisone—ankylosing spondylitis	9.5e-05	0.00186	CcSEcCtD
Ketoprofen—Shock—Dexamethasone—ankylosing spondylitis	9.48e-05	0.00185	CcSEcCtD
Ketoprofen—Shock—Betamethasone—ankylosing spondylitis	9.48e-05	0.00185	CcSEcCtD
Ketoprofen—Dyspnoea—Triamcinolone—ankylosing spondylitis	9.47e-05	0.00185	CcSEcCtD
Ketoprofen—Thrombocytopenia—Betamethasone—ankylosing spondylitis	9.43e-05	0.00184	CcSEcCtD
Ketoprofen—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	9.43e-05	0.00184	CcSEcCtD
Ketoprofen—Tachycardia—Dexamethasone—ankylosing spondylitis	9.4e-05	0.00184	CcSEcCtD
Ketoprofen—Tachycardia—Betamethasone—ankylosing spondylitis	9.4e-05	0.00184	CcSEcCtD
Ketoprofen—Angioedema—Prednisone—ankylosing spondylitis	9.39e-05	0.00184	CcSEcCtD
Ketoprofen—Dyspepsia—Triamcinolone—ankylosing spondylitis	9.35e-05	0.00183	CcSEcCtD
Ketoprofen—Erythema multiforme—Methotrexate—ankylosing spondylitis	9.33e-05	0.00182	CcSEcCtD
Ketoprofen—Dyspepsia—Methylprednisolone—ankylosing spondylitis	9.33e-05	0.00182	CcSEcCtD
Ketoprofen—Hyperhidrosis—Betamethasone—ankylosing spondylitis	9.31e-05	0.00182	CcSEcCtD
Ketoprofen—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	9.31e-05	0.00182	CcSEcCtD
Ketoprofen—Malaise—Prednisone—ankylosing spondylitis	9.27e-05	0.00181	CcSEcCtD
Ketoprofen—Vertigo—Prednisone—ankylosing spondylitis	9.24e-05	0.00181	CcSEcCtD
Ketoprofen—Tinnitus—Methotrexate—ankylosing spondylitis	9.2e-05	0.0018	CcSEcCtD
Ketoprofen—Anorexia—Dexamethasone—ankylosing spondylitis	9.18e-05	0.0018	CcSEcCtD
Ketoprofen—Anorexia—Betamethasone—ankylosing spondylitis	9.18e-05	0.0018	CcSEcCtD
Ketoprofen—Urticaria—Prednisolone—ankylosing spondylitis	9.17e-05	0.00179	CcSEcCtD
Ketoprofen—Fatigue—Triamcinolone—ankylosing spondylitis	9.15e-05	0.00179	CcSEcCtD
Ketoprofen—Fatigue—Methylprednisolone—ankylosing spondylitis	9.13e-05	0.00179	CcSEcCtD
Ketoprofen—Convulsion—Prednisone—ankylosing spondylitis	8.91e-05	0.00174	CcSEcCtD
Ketoprofen—Hypertension—Prednisone—ankylosing spondylitis	8.88e-05	0.00174	CcSEcCtD
Ketoprofen—Chills—Methotrexate—ankylosing spondylitis	8.86e-05	0.00173	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	8.78e-05	0.00172	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	8.78e-05	0.00172	CcSEcCtD
Ketoprofen—Myalgia—Prednisone—ankylosing spondylitis	8.75e-05	0.00171	CcSEcCtD
Ketoprofen—Feeling abnormal—Triamcinolone—ankylosing spondylitis	8.75e-05	0.00171	CcSEcCtD
Ketoprofen—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	8.73e-05	0.00171	CcSEcCtD
Ketoprofen—Anxiety—Prednisone—ankylosing spondylitis	8.72e-05	0.00171	CcSEcCtD
Ketoprofen—Alopecia—Methotrexate—ankylosing spondylitis	8.72e-05	0.00171	CcSEcCtD
Ketoprofen—Insomnia—Betamethasone—ankylosing spondylitis	8.71e-05	0.0017	CcSEcCtD
Ketoprofen—Insomnia—Dexamethasone—ankylosing spondylitis	8.71e-05	0.0017	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	8.66e-05	0.00169	CcSEcCtD
Ketoprofen—Paraesthesia—Betamethasone—ankylosing spondylitis	8.65e-05	0.00169	CcSEcCtD
Ketoprofen—Paraesthesia—Dexamethasone—ankylosing spondylitis	8.65e-05	0.00169	CcSEcCtD
Ketoprofen—Discomfort—Prednisone—ankylosing spondylitis	8.65e-05	0.00169	CcSEcCtD
Ketoprofen—Erythema—Methotrexate—ankylosing spondylitis	8.59e-05	0.00168	CcSEcCtD
Ketoprofen—Hypersensitivity—Prednisolone—ankylosing spondylitis	8.51e-05	0.00166	CcSEcCtD
Ketoprofen—Dyspepsia—Betamethasone—ankylosing spondylitis	8.48e-05	0.00166	CcSEcCtD
Ketoprofen—Dyspepsia—Dexamethasone—ankylosing spondylitis	8.48e-05	0.00166	CcSEcCtD
Ketoprofen—Urticaria—Triamcinolone—ankylosing spondylitis	8.44e-05	0.00165	CcSEcCtD
Ketoprofen—Urticaria—Methylprednisolone—ankylosing spondylitis	8.42e-05	0.00165	CcSEcCtD
Ketoprofen—Dysgeusia—Methotrexate—ankylosing spondylitis	8.41e-05	0.00165	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	8.41e-05	0.084	CbGpPWpGaD
Ketoprofen—Oedema—Prednisone—ankylosing spondylitis	8.39e-05	0.00164	CcSEcCtD
Ketoprofen—Anaphylactic shock—Prednisone—ankylosing spondylitis	8.39e-05	0.00164	CcSEcCtD
Ketoprofen—Abdominal pain—Methylprednisolone—ankylosing spondylitis	8.38e-05	0.00164	CcSEcCtD
Ketoprofen—Decreased appetite—Dexamethasone—ankylosing spondylitis	8.38e-05	0.00164	CcSEcCtD
Ketoprofen—Decreased appetite—Betamethasone—ankylosing spondylitis	8.38e-05	0.00164	CcSEcCtD
Ketoprofen—Infection—Prednisone—ankylosing spondylitis	8.34e-05	0.00163	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	8.32e-05	0.00163	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	8.32e-05	0.00163	CcSEcCtD
Ketoprofen—Fatigue—Betamethasone—ankylosing spondylitis	8.31e-05	0.00162	CcSEcCtD
Ketoprofen—Fatigue—Dexamethasone—ankylosing spondylitis	8.31e-05	0.00162	CcSEcCtD
Ketoprofen—Shock—Prednisone—ankylosing spondylitis	8.25e-05	0.00161	CcSEcCtD
Ketoprofen—Tachycardia—Prednisone—ankylosing spondylitis	8.19e-05	0.0016	CcSEcCtD
Ketoprofen—Hyperhidrosis—Prednisone—ankylosing spondylitis	8.11e-05	0.00159	CcSEcCtD
Ketoprofen—Anorexia—Prednisone—ankylosing spondylitis	8e-05	0.00156	CcSEcCtD
Ketoprofen—Ill-defined disorder—Methotrexate—ankylosing spondylitis	7.97e-05	0.00156	CcSEcCtD
Ketoprofen—Anaemia—Methotrexate—ankylosing spondylitis	7.94e-05	0.00155	CcSEcCtD
Ketoprofen—Feeling abnormal—Dexamethasone—ankylosing spondylitis	7.94e-05	0.00155	CcSEcCtD
Ketoprofen—Feeling abnormal—Betamethasone—ankylosing spondylitis	7.94e-05	0.00155	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	7.88e-05	0.00154	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	7.88e-05	0.00154	CcSEcCtD
Ketoprofen—Hypersensitivity—Triamcinolone—ankylosing spondylitis	7.82e-05	0.00153	CcSEcCtD
Ketoprofen—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	7.81e-05	0.00153	CcSEcCtD
Ketoprofen—Malaise—Methotrexate—ankylosing spondylitis	7.75e-05	0.00152	CcSEcCtD
Ketoprofen—Vertigo—Methotrexate—ankylosing spondylitis	7.72e-05	0.00151	CcSEcCtD
Ketoprofen—Urticaria—Dexamethasone—ankylosing spondylitis	7.65e-05	0.0015	CcSEcCtD
Ketoprofen—Urticaria—Betamethasone—ankylosing spondylitis	7.65e-05	0.0015	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	7.64e-05	0.00149	CcSEcCtD
Ketoprofen—Dizziness—Prednisolone—ankylosing spondylitis	7.64e-05	0.00149	CcSEcCtD
Ketoprofen—Asthenia—Triamcinolone—ankylosing spondylitis	7.62e-05	0.00149	CcSEcCtD
Ketoprofen—Abdominal pain—Betamethasone—ankylosing spondylitis	7.62e-05	0.00149	CcSEcCtD
Ketoprofen—Abdominal pain—Dexamethasone—ankylosing spondylitis	7.62e-05	0.00149	CcSEcCtD
Ketoprofen—Asthenia—Methylprednisolone—ankylosing spondylitis	7.6e-05	0.00149	CcSEcCtD
Ketoprofen—Insomnia—Prednisone—ankylosing spondylitis	7.59e-05	0.00148	CcSEcCtD
Ketoprofen—Paraesthesia—Prednisone—ankylosing spondylitis	7.53e-05	0.00147	CcSEcCtD
Ketoprofen—Pruritus—Triamcinolone—ankylosing spondylitis	7.51e-05	0.00147	CcSEcCtD
Ketoprofen—Pruritus—Methylprednisolone—ankylosing spondylitis	7.5e-05	0.00147	CcSEcCtD
Ketoprofen—Convulsion—Methotrexate—ankylosing spondylitis	7.44e-05	0.00146	CcSEcCtD
Ketoprofen—Dyspepsia—Prednisone—ankylosing spondylitis	7.39e-05	0.00144	CcSEcCtD
Ketoprofen—Myalgia—Methotrexate—ankylosing spondylitis	7.31e-05	0.00143	CcSEcCtD
Ketoprofen—Decreased appetite—Prednisone—ankylosing spondylitis	7.29e-05	0.00143	CcSEcCtD
Ketoprofen—Rash—Prednisolone—ankylosing spondylitis	7.28e-05	0.00142	CcSEcCtD
Ketoprofen—Dermatitis—Prednisolone—ankylosing spondylitis	7.27e-05	0.00142	CcSEcCtD
Ketoprofen—Diarrhoea—Methylprednisolone—ankylosing spondylitis	7.25e-05	0.00142	CcSEcCtD
Ketoprofen—Fatigue—Prednisone—ankylosing spondylitis	7.23e-05	0.00141	CcSEcCtD
Ketoprofen—Headache—Prednisolone—ankylosing spondylitis	7.23e-05	0.00141	CcSEcCtD
Ketoprofen—Discomfort—Methotrexate—ankylosing spondylitis	7.23e-05	0.00141	CcSEcCtD
Ketoprofen—Constipation—Prednisone—ankylosing spondylitis	7.17e-05	0.0014	CcSEcCtD
Ketoprofen—Confusional state—Methotrexate—ankylosing spondylitis	7.07e-05	0.00138	CcSEcCtD
Ketoprofen—Dizziness—Triamcinolone—ankylosing spondylitis	7.02e-05	0.00137	CcSEcCtD
Ketoprofen—Anaphylactic shock—Methotrexate—ankylosing spondylitis	7.01e-05	0.00137	CcSEcCtD
Ketoprofen—Dizziness—Methylprednisolone—ankylosing spondylitis	7.01e-05	0.00137	CcSEcCtD
Ketoprofen—Infection—Methotrexate—ankylosing spondylitis	6.97e-05	0.00136	CcSEcCtD
Ketoprofen—Feeling abnormal—Prednisone—ankylosing spondylitis	6.91e-05	0.00135	CcSEcCtD
Ketoprofen—Asthenia—Dexamethasone—ankylosing spondylitis	6.91e-05	0.00135	CcSEcCtD
Ketoprofen—Asthenia—Betamethasone—ankylosing spondylitis	6.91e-05	0.00135	CcSEcCtD
Ketoprofen—Thrombocytopenia—Methotrexate—ankylosing spondylitis	6.87e-05	0.00134	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Prednisone—ankylosing spondylitis	6.86e-05	0.00134	CcSEcCtD
Ketoprofen—Nausea—Prednisolone—ankylosing spondylitis	6.86e-05	0.00134	CcSEcCtD
Ketoprofen—Pruritus—Dexamethasone—ankylosing spondylitis	6.82e-05	0.00133	CcSEcCtD
Ketoprofen—Pruritus—Betamethasone—ankylosing spondylitis	6.82e-05	0.00133	CcSEcCtD
Ketoprofen—Hyperhidrosis—Methotrexate—ankylosing spondylitis	6.78e-05	0.00133	CcSEcCtD
Ketoprofen—Vomiting—Triamcinolone—ankylosing spondylitis	6.75e-05	0.00132	CcSEcCtD
Ketoprofen—Vomiting—Methylprednisolone—ankylosing spondylitis	6.74e-05	0.00132	CcSEcCtD
Ketoprofen—Rash—Triamcinolone—ankylosing spondylitis	6.69e-05	0.00131	CcSEcCtD
Ketoprofen—Dermatitis—Triamcinolone—ankylosing spondylitis	6.69e-05	0.00131	CcSEcCtD
Ketoprofen—Anorexia—Methotrexate—ankylosing spondylitis	6.68e-05	0.00131	CcSEcCtD
Ketoprofen—Rash—Methylprednisolone—ankylosing spondylitis	6.68e-05	0.00131	CcSEcCtD
Ketoprofen—Dermatitis—Methylprednisolone—ankylosing spondylitis	6.67e-05	0.0013	CcSEcCtD
Ketoprofen—Urticaria—Prednisone—ankylosing spondylitis	6.67e-05	0.0013	CcSEcCtD
Ketoprofen—Headache—Triamcinolone—ankylosing spondylitis	6.65e-05	0.0013	CcSEcCtD
Ketoprofen—Headache—Methylprednisolone—ankylosing spondylitis	6.64e-05	0.0013	CcSEcCtD
Ketoprofen—Abdominal pain—Prednisone—ankylosing spondylitis	6.63e-05	0.0013	CcSEcCtD
Ketoprofen—Diarrhoea—Betamethasone—ankylosing spondylitis	6.59e-05	0.00129	CcSEcCtD
Ketoprofen—Diarrhoea—Dexamethasone—ankylosing spondylitis	6.59e-05	0.00129	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	6.39e-05	0.00125	CcSEcCtD
Ketoprofen—Dizziness—Betamethasone—ankylosing spondylitis	6.37e-05	0.00125	CcSEcCtD
Ketoprofen—Dizziness—Dexamethasone—ankylosing spondylitis	6.37e-05	0.00125	CcSEcCtD
Ketoprofen—Insomnia—Methotrexate—ankylosing spondylitis	6.34e-05	0.00124	CcSEcCtD
Ketoprofen—Nausea—Triamcinolone—ankylosing spondylitis	6.31e-05	0.00123	CcSEcCtD
Ketoprofen—Paraesthesia—Methotrexate—ankylosing spondylitis	6.3e-05	0.00123	CcSEcCtD
Ketoprofen—Nausea—Methylprednisolone—ankylosing spondylitis	6.29e-05	0.00123	CcSEcCtD
Ketoprofen—Dyspnoea—Methotrexate—ankylosing spondylitis	6.25e-05	0.00122	CcSEcCtD
Ketoprofen—Somnolence—Methotrexate—ankylosing spondylitis	6.23e-05	0.00122	CcSEcCtD
Ketoprofen—Hypersensitivity—Prednisone—ankylosing spondylitis	6.18e-05	0.00121	CcSEcCtD
Ketoprofen—Dyspepsia—Methotrexate—ankylosing spondylitis	6.17e-05	0.00121	CcSEcCtD
Ketoprofen—Vomiting—Dexamethasone—ankylosing spondylitis	6.13e-05	0.0012	CcSEcCtD
Ketoprofen—Vomiting—Betamethasone—ankylosing spondylitis	6.13e-05	0.0012	CcSEcCtD
Ketoprofen—Decreased appetite—Methotrexate—ankylosing spondylitis	6.1e-05	0.00119	CcSEcCtD
Ketoprofen—Rash—Dexamethasone—ankylosing spondylitis	6.07e-05	0.00119	CcSEcCtD
Ketoprofen—Rash—Betamethasone—ankylosing spondylitis	6.07e-05	0.00119	CcSEcCtD
Ketoprofen—Dermatitis—Betamethasone—ankylosing spondylitis	6.07e-05	0.00119	CcSEcCtD
Ketoprofen—Dermatitis—Dexamethasone—ankylosing spondylitis	6.07e-05	0.00119	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	6.05e-05	0.00118	CcSEcCtD
Ketoprofen—Fatigue—Methotrexate—ankylosing spondylitis	6.05e-05	0.00118	CcSEcCtD
Ketoprofen—Headache—Betamethasone—ankylosing spondylitis	6.04e-05	0.00118	CcSEcCtD
Ketoprofen—Headache—Dexamethasone—ankylosing spondylitis	6.04e-05	0.00118	CcSEcCtD
Ketoprofen—Asthenia—Prednisone—ankylosing spondylitis	6.02e-05	0.00118	CcSEcCtD
Ketoprofen—Pruritus—Prednisone—ankylosing spondylitis	5.94e-05	0.00116	CcSEcCtD
Ketoprofen—Feeling abnormal—Methotrexate—ankylosing spondylitis	5.78e-05	0.00113	CcSEcCtD
Ketoprofen—Diarrhoea—Prednisone—ankylosing spondylitis	5.74e-05	0.00112	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	5.73e-05	0.00112	CcSEcCtD
Ketoprofen—Nausea—Dexamethasone—ankylosing spondylitis	5.72e-05	0.00112	CcSEcCtD
Ketoprofen—Nausea—Betamethasone—ankylosing spondylitis	5.72e-05	0.00112	CcSEcCtD
Ketoprofen—Urticaria—Methotrexate—ankylosing spondylitis	5.57e-05	0.00109	CcSEcCtD
Ketoprofen—Dizziness—Prednisone—ankylosing spondylitis	5.55e-05	0.00108	CcSEcCtD
Ketoprofen—Abdominal pain—Methotrexate—ankylosing spondylitis	5.54e-05	0.00108	CcSEcCtD
Ketoprofen—Vomiting—Prednisone—ankylosing spondylitis	5.33e-05	0.00104	CcSEcCtD
Ketoprofen—Rash—Prednisone—ankylosing spondylitis	5.29e-05	0.00103	CcSEcCtD
Ketoprofen—Dermatitis—Prednisone—ankylosing spondylitis	5.29e-05	0.00103	CcSEcCtD
Ketoprofen—Headache—Prednisone—ankylosing spondylitis	5.26e-05	0.00103	CcSEcCtD
Ketoprofen—Hypersensitivity—Methotrexate—ankylosing spondylitis	5.17e-05	0.00101	CcSEcCtD
Ketoprofen—Asthenia—Methotrexate—ankylosing spondylitis	5.03e-05	0.000984	CcSEcCtD
Ketoprofen—Nausea—Prednisone—ankylosing spondylitis	4.98e-05	0.000975	CcSEcCtD
Ketoprofen—Pruritus—Methotrexate—ankylosing spondylitis	4.96e-05	0.00097	CcSEcCtD
Ketoprofen—Diarrhoea—Methotrexate—ankylosing spondylitis	4.8e-05	0.000938	CcSEcCtD
Ketoprofen—Dizziness—Methotrexate—ankylosing spondylitis	4.64e-05	0.000907	CcSEcCtD
Ketoprofen—Vomiting—Methotrexate—ankylosing spondylitis	4.46e-05	0.000872	CcSEcCtD
Ketoprofen—Rash—Methotrexate—ankylosing spondylitis	4.42e-05	0.000865	CcSEcCtD
Ketoprofen—Dermatitis—Methotrexate—ankylosing spondylitis	4.42e-05	0.000864	CcSEcCtD
Ketoprofen—Headache—Methotrexate—ankylosing spondylitis	4.39e-05	0.000859	CcSEcCtD
Ketoprofen—CXCL8—Overview of nanoparticle effects—CRP—ankylosing spondylitis	4.32e-05	0.0431	CbGpPWpGaD
Ketoprofen—Nausea—Methotrexate—ankylosing spondylitis	4.17e-05	0.000814	CcSEcCtD
Ketoprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	2.94e-05	0.0293	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-C—ankylosing spondylitis	2.64e-05	0.0264	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL17A—ankylosing spondylitis	2.42e-05	0.0241	CbGpPWpGaD
Ketoprofen—PTGS1—Overview of nanoparticle effects—CRP—ankylosing spondylitis	2.38e-05	0.0238	CbGpPWpGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	2.37e-05	0.0236	CbGpPWpGaD
Ketoprofen—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	2.33e-05	0.0233	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL12B—ankylosing spondylitis	2.25e-05	0.0224	CbGpPWpGaD
Ketoprofen—CXCR1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	2.11e-05	0.0211	CbGpPWpGaD
Ketoprofen—CXCL8—Overview of nanoparticle effects—TNF—ankylosing spondylitis	1.95e-05	0.0195	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	1.93e-05	0.0193	CbGpPWpGaD
Ketoprofen—PTGS2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	1.89e-05	0.0189	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	1.83e-05	0.0183	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—IL10—ankylosing spondylitis	1.81e-05	0.0181	CbGpPWpGaD
Ketoprofen—CXCR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	1.81e-05	0.018	CbGpPWpGaD
Ketoprofen—SLC22A11—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.68e-05	0.0168	CbGpPWpGaD
Ketoprofen—CXCL8—EBV LMP1 signaling—TNF—ankylosing spondylitis	1.68e-05	0.0168	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL1A—ankylosing spondylitis	1.65e-05	0.0165	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL10—ankylosing spondylitis	1.64e-05	0.0164	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—CD40LG—ankylosing spondylitis	1.64e-05	0.0164	CbGpPWpGaD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	1.6e-05	0.016	CbGpPWpGaD
Ketoprofen—CXCL8—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	1.59e-05	0.0159	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-B—ankylosing spondylitis	1.56e-05	0.0156	CbGpPWpGaD
Ketoprofen—SLC22A7—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.52e-05	0.0152	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—HLA-A—ankylosing spondylitis	1.45e-05	0.0145	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	1.43e-05	0.0143	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR ligand binding—PTGER4—ankylosing spondylitis	1.38e-05	0.0137	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	1.33e-05	0.0133	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	1.32e-05	0.0131	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL1A—ankylosing spondylitis	1.32e-05	0.0131	CbGpPWpGaD
Ketoprofen—SLC22A8—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.28e-05	0.0128	CbGpPWpGaD
Ketoprofen—ABCC4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.23e-05	0.0123	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IL1A—ankylosing spondylitis	1.2e-05	0.012	CbGpPWpGaD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	1.17e-05	0.0117	CbGpPWpGaD
Ketoprofen—SLCO1A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.14e-05	0.0114	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	1.08e-05	0.0108	CbGpPWpGaD
Ketoprofen—PTGS1—Overview of nanoparticle effects—TNF—ankylosing spondylitis	1.08e-05	0.0108	CbGpPWpGaD
Ketoprofen—SLC22A6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	1.07e-05	0.0107	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	1.04e-05	0.0104	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TLR4—ankylosing spondylitis	9.6e-06	0.00959	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	9.58e-06	0.00957	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	9.53e-06	0.00952	CbGpPWpGaD
Ketoprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	9.01e-06	0.009	CbGpPWpGaD
Ketoprofen—PTGS2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	8.56e-06	0.00855	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	8.42e-06	0.00841	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—IL1A—ankylosing spondylitis	8.32e-06	0.00832	CbGpPWpGaD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	8.15e-06	0.00814	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	7.77e-06	0.00777	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—PTGER4—ankylosing spondylitis	7.06e-06	0.00705	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	6.99e-06	0.00698	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	6.94e-06	0.00694	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—B3GNT2—ankylosing spondylitis	6.37e-06	0.00636	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—IL1A—ankylosing spondylitis	6.29e-06	0.00628	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—TNF—ankylosing spondylitis	6.25e-06	0.00624	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR ligand binding—PTGER4—ankylosing spondylitis	6.21e-06	0.0062	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—CRP—ankylosing spondylitis	5.65e-06	0.00564	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.56e-06	0.00555	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—CRP—ankylosing spondylitis	5.55e-06	0.00554	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL1A—ankylosing spondylitis	5.25e-06	0.00524	CbGpPWpGaD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	5.09e-06	0.00509	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—MMP3—ankylosing spondylitis	5.03e-06	0.00502	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TNF—ankylosing spondylitis	4.53e-06	0.00453	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—CRP—ankylosing spondylitis	4.49e-06	0.00448	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	4.22e-06	0.00421	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TLR4—ankylosing spondylitis	4.21e-06	0.0042	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PTGER4—ankylosing spondylitis	4.17e-06	0.00417	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	3.98e-06	0.00397	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	3.95e-06	0.00394	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	3.63e-06	0.00362	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PTGER4—ankylosing spondylitis	3.51e-06	0.0035	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PTGER4—ankylosing spondylitis	3.19e-06	0.00318	CbGpPWpGaD
Ketoprofen—PTGS1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	3.16e-06	0.00316	CbGpPWpGaD
Ketoprofen—ALB—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	3.14e-06	0.00314	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MMP3—ankylosing spondylitis	2.97e-06	0.00297	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ANTXR2—ankylosing spondylitis	2.91e-06	0.00291	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TNF—ankylosing spondylitis	2.56e-06	0.00255	CbGpPWpGaD
Ketoprofen—PTGS2—Selenium Micronutrient Network—TNF—ankylosing spondylitis	2.51e-06	0.00251	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—B3GNT2—ankylosing spondylitis	2.38e-06	0.00238	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—MMP3—ankylosing spondylitis	2.27e-06	0.00227	CbGpPWpGaD
Ketoprofen—ALB—Selenium Micronutrient Network—TNF—ankylosing spondylitis	2.03e-06	0.00203	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TNF—ankylosing spondylitis	1.99e-06	0.00198	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTGER4—ankylosing spondylitis	1.88e-06	0.00188	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—B3GNT2—ankylosing spondylitis	1.81e-06	0.00181	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—B3GNT2—ankylosing spondylitis	1.72e-06	0.00171	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—B3GNT2—ankylosing spondylitis	1.44e-06	0.00144	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.35e-06	0.00135	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP3—ankylosing spondylitis	1.34e-06	0.00134	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	1.17e-06	0.00117	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—B3GNT2—ankylosing spondylitis	1.16e-06	0.00116	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	9.52e-07	0.000951	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HLA-A—ankylosing spondylitis	6.95e-07	0.000694	CbGpPWpGaD
